names of glp-1 glp 1 receptor agonists brand Understanding Agonists: Key Insights for Payers GLP-1 receptor agonists | How

There was more hypoglycemia and weight gain (+1.1 kg) in the glipizide group, whereas the sitagliptin group had weight loss (-1.5 kg)

Orforglipron is expected to receive an FDA decision in the first half of 2026 (likely Q2)

Furthermore, theres a risk of depression and suicidal thoughts

[DOI] [PMC free article] [PubMed] [Google Scholar] 170.Najm A., Niculescu A.G., Grumezescu A.M., Beuran M

But if left untreated over time, this side effect can cause serious problems, including dangerous heart rhythms and even death

Some researchers have moved their eyes to small-molecule GLP-1RA - with high oral bioavailability, and high patient compliance